With Hikma's strong regional footprint and medical expertise, we expect the Alluminox™ platform to make significant progress in MENA." * Rakuten Medical's therapies based on Alluminox™ platform are investigational outside of Japan, and not approved in MENA for investigational or commercial use. About Alluminox™ platformThe Alluminox™ platform is an investigational technology platform based on a cancer therapy called photoimmunotherapy, which was developed by Dr. Hisataka Kobayashi and team from the National Cancer Institute in the United States. Rakuten Medical is developing the Alluminox platform as a technology consisting of a drug, device, and other related components. Contact UsSOURCE Rakuten Medical, Inc.

Source: The North Africa Journal August 10, 2023 12:29 UTC